Statistics at a Glance

At a Glance

Estimated New Cases in 2019 22,530

% of All New Cancer Cases 1.3%

Estimated Deaths in 2019 13,980

% of All Cancer Deaths 2.3%

Percent Surviving
5 Years

47.6% 2009-2015
Year New Cases - SEER 9 New Cases - SEER 13 Deaths - U.S. Percent Surviving 5 Years - SEER 9
Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend
1975 16.32 15.68 - - 9.84 9.91 33.81% 33.54%
1976 15.84 15.69 - - 10.02 9.79 37.04% 33.99%
1977 15.62 15.71 - - 9.58 9.67 37.64% 34.45%
1978 15.39 15.72 - - 9.55 9.55 37.51% 34.90%
1979 15.39 15.74 - - 9.33 9.44 37.66% 35.36%
1980 15.46 15.76 - - 9.29 9.32 38.42% 35.82%
1981 15.43 15.77 - - 9.23 9.21 39.12% 36.27%
1982 15.59 15.79 - - 9.22 9.09 37.04% 36.73%
1983 15.97 15.80 - - 9.20 9.12 41.12% 37.19%
1984 16.26 15.82 - - 9.11 9.16 39.41% 37.64%
1985 16.55 15.83 - - 9.08 9.19 38.96% 38.10%
1986 15.01 15.85 - - 9.24 9.22 37.53% 38.56%
1987 16.15 15.87 - - 9.18 9.25 38.15% 39.01%
1988 15.28 15.72 - - 9.31 9.28 39.85% 39.47%
1989 15.52 15.58 - - 9.21 9.31 37.43% 39.92%
1990 15.39 15.43 - - 9.33 9.34 40.68% 40.38%
1991 15.78 15.29 - - 9.51 9.38 39.88% 40.83%
1992 14.94 15.15 14.90 15.05 9.46 9.41 42.05% 41.29%
1993 15.26 15.01 15.18 14.90 9.08 9.30 38.76% 41.74%
1994 14.49 14.87 14.41 14.76 9.38 9.19 44.42% 42.19%
1995 14.60 14.74 14.57 14.61 9.12 9.08 42.62% 42.64%
1996 14.13 14.60 13.99 14.47 8.86 8.98 42.46% 43.09%
1997 14.73 14.47 14.22 14.33 8.94 8.87 44.49% 43.54%
1998 14.36 14.34 14.15 14.19 8.73 8.77 45.68% 43.99%
1999 14.73 14.21 14.34 14.06 8.77 8.82 43.14% 44.44%
2000 14.36 14.07 14.22 13.92 8.89 8.87 43.38% 44.89%
2001 14.62 13.95 14.25 13.78 9.00 8.93 46.22% 45.33%
2002 13.89 13.82 13.90 13.65 9.04 8.98 43.06% 45.78%
2003 13.72 13.69 13.56 13.52 8.87 9.03 44.74% 46.22%
2004 13.38 13.57 13.20 13.39 8.78 8.83 44.81% 46.66%
2005 13.01 13.44 13.21 13.26 8.66 8.63 45.02% 47.10%
2006 13.00 13.32 12.88 13.13 8.56 8.44 45.97% 47.54%
2007 13.07 13.20 13.16 13.00 8.25 8.25 44.89% 47.98%
2008 12.95 13.07 13.00 12.88 7.98 8.06 47.01% 48.42%
2009 13.05 12.95 12.78 12.75 7.85 7.88 47.34% 48.85%
2010 12.88 12.84 12.59 12.63 7.80 7.70 47.45% 49.29%
2011 12.38 12.45 12.29 12.51 7.54 7.53 49.41% 49.72%
2012 12.06 12.08 12.44 12.38 7.40 7.36 - 50.15%
2013 11.61 11.72 11.61 11.96 7.20 7.19 - 50.58%
2014 11.61 11.37 11.54 11.56 7.02 7.03 - 51.01%
2015 11.59 11.03 11.69 11.16 6.74 6.87 - 51.43%
2016 10.12 10.70 10.47 10.78 6.76 6.71 - 51.86%

Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.


Number of New Cases and Deaths per 100,000: The number of new cases of ovarian cancer was 11.4 per 100,000 women per year. The number of deaths was 7.0 per 100,000 women per year. These rates are age-adjusted and based on 2012-2016 cases and deaths.

Lifetime Risk of Developing Cancer: Approximately 1.3 percent of women will be diagnosed with ovarian cancer at some point during their lifetime, based on 2014-2016 data.

Prevalence of This Cancer: In 2016, there were an estimated 229,875 women living with ovarian cancer in the United States.

Did You Know? Video Series

Survival Statistics

How Many People Survive 5 Years Or More after Being Diagnosed with Ovarian Cancer?

Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

47.6%

Percent Surviving
5 Years

47.6%

Based on data from SEER 18 2009-2015. Gray figures represent those who have died from ovarian cancer. Green figures represent those who have survived 5 years or more.

Additional Information

Survival by Stage

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier ovarian cancer is caught, the better chance a person has of surviving five years after being diagnosed. For ovarian cancer, 14.9% are diagnosed at the local stage. The 5-year survival for localized ovarian cancer is 92.4%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Ovarian Cancer
Stage Percent of Cases 5-Year Relative Survival
Localized
Confined to Primary Site
15% 92.4%
Regional
Spread to Regional Lymph Nodes
21% 75.2%
Distant
Cancer Has Metastasized
59% 29.2%
Unknown
Unstaged
6% 24.3%

SEER 18 2009-2015, All Races, Females by SEER Summary Stage 2000

Additional Information

Number of New Cases and Deaths

How Common Is This Cancer?

Compared to other cancers, ovarian cancer is relatively rare.

Rank Common Types of Cancer Estimated New
Cases 2019
Estimated
Deaths 2019
1. Breast Cancer (Female) 268,600 41,760
2. Lung and Bronchus Cancer 228,150 142,670
3. Prostate Cancer 174,650 31,620
4. Colorectal Cancer 145,600 51,020
5. Melanoma of the Skin 96,480 7,230
6. Bladder Cancer 80,470 17,670
7. Non-Hodgkin Lymphoma 74,200 19,970
8. Kidney and Renal Pelvis Cancer 73,820 14,770
9. Uterine Cancer 61,880 12,160
10. Leukemia 61,780 22,840
- - -
17. Ovarian Cancer 22,530 13,980

Ovarian cancer represents 1.3% of all new cancer cases in the U.S.

1.3%

In 2019, it is estimated that there will be 22,530 new cases of ovarian cancer and an estimated 13,980 people will die of this disease.

Who Gets This Cancer?

Ovarian cancer is rare. Women with a family history of ovarian cancer have an increased risk for the disease. The number of new cases of ovarian cancer was 11.4 per 100,000 women per year based on 2012-2016 cases.

Number of New Cases per 100,000 Persons by Race/Ethnicity: Ovarian Cancer
Males
All Races Sex-specific cancer type
White
Black
Asian/Pacific Islander
American Indian/Alaska Native
Hispanic
Non-Hispanic
Females
All Races 11.4
White 11.9
Black 9.2
Asian/Pacific Islander 9.4
American Indian/Alaska Native 8.1
Hispanic 10.3
Non-Hispanic 11.6

SEER 21 2012-2016, Age-Adjusted

Percent of New Cases by Age Group: Ovarian Cancer
Age Range Percent of New Cases
<20 1.3%
20-34 4.0%
35-44 6.7%
45-54 17.5%
55-64 24.7%
65-74 22.6%
75-84 15.3%
>84 7.9%

Ovarian cancer is most frequently diagnosed among women aged 55-64.

Median Age
At Diagnosis

63

SEER 21 2012-2016, All Races, Females

Who Dies From This Cancer?

For ovarian cancer, death rates generally increase with age. Ovarian cancer is the thirteenth leading cause of cancer death in the United States. The number of deaths was 7.0 per 100,000 women per year based on 2012-2016.

Number of Deaths per 100,000 Persons by Race/Ethnicity: Ovarian Cancer
Males
All Races Sex-specific cancer type
White
Black
Asian/Pacific Islander
American Indian/Alaska Native
Hispanic
Non-Hispanic
Females
All Races 7.0
White 7.3
Black 6.1
Asian/Pacific Islander 4.4
American Indian/Alaska Native 6.3
Hispanic 5.2
Non-Hispanic 7.2

U.S. 2012-2016, Age-Adjusted

Percent of Deaths by Age Group: Ovarian Cancer
Age Range Percent of Deaths
<20 0.1%
20-34 0.7%
35-44 2.3%
45-54 9.6%
55-64 21.2%
65-74 27.5%
75-84 24.5%
>84 14.2%

The percent of ovarian cancer deaths is highest among women aged 65-74.

Median Age
At Death

70

U.S. 2012-2016, All Races, Females

Trends in Rates

Changes Over Time

Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, rates for new ovarian cancer cases have been falling on average 2.3% each year over the last 10 years. Death rates have been falling on average 2.3% each year over 2007-2016. 5-year survival trends are shown below.

More About This Cancer

Cancer and the Ovary

Figure: Female Reproductive Anatomy

Figure: Anatomy of the female reproductive system; drawing shows the uterus, myometrium (muscular outer layer of the uterus), endometrium (inner lining of the uterus), ovaries, fallopian tubes, cervix, and vagina.

The ovaries are a pair of organs in the female reproductive system. They are in the pelvis, one on each side of the uterus (the hollow, pear-shaped organ where a fetus grows). Each ovary is about the size and shape of an almond. The ovaries make eggs and female hormones (chemicals that control the way certain cells or organs work).

Additional Information

More Information

Here are some resources for learning more about ovarian cancer.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:

Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Ovarian Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/ovary.html

These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.